+

GR3033990T3 - Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics - Google Patents

Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics

Info

Publication number
GR3033990T3
GR3033990T3 GR20000401676T GR20000401676T GR3033990T3 GR 3033990 T3 GR3033990 T3 GR 3033990T3 GR 20000401676 T GR20000401676 T GR 20000401676T GR 20000401676 T GR20000401676 T GR 20000401676T GR 3033990 T3 GR3033990 T3 GR 3033990T3
Authority
GR
Greece
Prior art keywords
fatty acids
pct
polyunsaturated fatty
cosmetics
therapy
Prior art date
Application number
GR20000401676T
Other languages
English (en)
Inventor
Jean-Robert Grinda
Original Assignee
Grinda Jean Robert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grinda Jean Robert filed Critical Grinda Jean Robert
Publication of GR3033990T3 publication Critical patent/GR3033990T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03Monocarboxylic acids
    • C07C57/12Straight chain carboxylic acids containing eighteen carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/50Use of additives, e.g. for stabilisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Multi-Conductor Connections (AREA)
  • Coupling Device And Connection With Printed Circuit (AREA)
GR20000401676T 1994-07-15 2000-07-21 Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics GR3033990T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9408810A FR2722410B1 (fr) 1994-07-15 1994-07-15 Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique
PCT/FR1995/000949 WO1996002488A1 (fr) 1994-07-15 1995-07-17 Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises en therapeutique et en cosmetologie

Publications (1)

Publication Number Publication Date
GR3033990T3 true GR3033990T3 (en) 2000-11-30

Family

ID=9465440

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401676T GR3033990T3 (en) 1994-07-15 2000-07-21 Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics

Country Status (14)

Country Link
US (1) US5914347A (el)
EP (1) EP0796238B1 (el)
JP (1) JPH10508287A (el)
KR (1) KR100388818B1 (el)
AT (1) ATE193006T1 (el)
DE (1) DE69517050T2 (el)
DK (1) DK0796238T3 (el)
ES (1) ES2150004T3 (el)
FR (1) FR2722410B1 (el)
GR (1) GR3033990T3 (el)
MX (1) MX9701771A (el)
NZ (1) NZ289877A (el)
PT (1) PT796238E (el)
WO (1) WO1996002488A1 (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741533B1 (fr) * 1995-11-28 1998-02-06 Grinda Jean Robert Procede de stabilisation des acides gras polyinsatures et utilisation de ces produits stabilises en cosmetologie
EP2280062A3 (en) * 1996-03-28 2011-09-28 DSM IP Assets B.V. Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
FR2802810A1 (fr) * 1999-12-23 2001-06-29 Grinda Jean Robert Nouveaux produits cosmetiques et therapeutiques a base de composes lipidiques et leur procede de preparation
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
EP2324828A1 (en) 2003-08-18 2011-05-25 BTG International Limited Treatment for neurodegenerative conditions
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US10052299B2 (en) * 2009-10-30 2018-08-21 Retrotope, Inc. Alleviating oxidative stress disorders with PUFA derivatives
JPWO2012153832A1 (ja) 2011-05-12 2014-07-31 日本水産株式会社 炎症性疾患用皮膚外用組成物
CN112980897A (zh) 2013-12-04 2021-06-18 日本水产株式会社 含有二高-γ-亚麻酸的微生物油的制备方法
KR102643910B1 (ko) 2015-11-23 2024-03-06 레트로토프 인코포레이티드 1,4-다이엔 시스템에 대한 부위 특이적인 동위원소 표지법
WO2021168311A1 (en) 2020-02-21 2021-08-26 Retrotope, Inc. Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2827452A (en) * 1955-05-31 1958-03-18 Univ Minnesota Stabilization of materials
US3450821A (en) * 1967-03-02 1969-06-17 Hoffmann La Roche Stable compositions containing eicosatetrayn - (5,8,11,14) - oic-(1) acid and derivatives thereof
JPS60258139A (ja) * 1984-06-05 1985-12-20 Nippon Oil & Fats Co Ltd 金属石けんの水分散体
FR2573653B1 (fr) * 1984-11-23 1988-02-26 Pf Medicament Compositions pharmaceutiques antiandrogenes a base d'acides gras
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid

Also Published As

Publication number Publication date
FR2722410A1 (fr) 1996-01-19
DK0796238T3 (da) 2000-10-02
KR100388818B1 (ko) 2003-10-17
DE69517050D1 (de) 2000-06-21
NZ289877A (en) 1998-05-27
MX9701771A (es) 1997-12-31
EP0796238A1 (fr) 1997-09-24
EP0796238B1 (fr) 2000-05-17
US5914347A (en) 1999-06-22
DE69517050T2 (de) 2001-01-18
FR2722410B1 (fr) 1996-10-04
ES2150004T3 (es) 2000-11-16
PT796238E (pt) 2000-09-29
ATE193006T1 (de) 2000-06-15
JPH10508287A (ja) 1998-08-18
WO1996002488A1 (fr) 1996-02-01
KR970706230A (ko) 1997-11-03

Similar Documents

Publication Publication Date Title
GR3033990T3 (en) Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics
JP2705910B2 (ja) 活性剤前駆体を含有する化粧または皮膚用の安定化した組成物、およびその使用方法
US5147859A (en) Complexes of glycerrhetinic acid with phospholipids and pharmaceutical and cosmetic compositions containing them
US5788972A (en) Product for topical application containing a lipase and an active ingredient precursor
US7344868B2 (en) Method for synthesizing ceramide-type compounds
HUP9802308A2 (hu) Bioaktív zsírsavészterek és eljárás a vegyületeket tartalmazó gyógyszerkészítmények előállítására
YU66600A (sh) Farmaceutski preparati koji mogu da budu gelirani
JP2002529370A (ja) 乾燥型エモリエント剤組成物
MY110734A (en) Improvements in or relating to dioic acids.
JP2001503066A (ja) アスコルビル−ホスホリル−コレステロール
AU6720000A (en) New process for the preparation of conjugated linoleic acid (cla)
GB2199494A (en) Dispersion of lipidic spherules
AU5309794A (en) Pharmaceutical compositions containing nanocapsules
CA2120511A1 (en) Pharmaceutical and/or cosmetic composition and the use thereof
BR0009340A (pt) Composição adequada para uso na pele ou no cabelo, produto para aplicação na pele ou no cabelo, método para preparar uma composição adequada para aplicação na pele ou no cabelo, e, uso de uma composição
DE69313073T2 (de) Lanolin fettsäure, ihre abtrennung, und kosmetische- und äusserlich anzuwendende zubereitung
US6153205A (en) Topical application product containing a lipase, a vitamin precursor and a fatty alcohol
JP2993943B2 (ja) ホスホン酸誘導体とメタ二亜硫酸塩に基づくアスコルビン酸安定化のための安定剤とそれを含有する組成物
EP0084341B2 (en) Emulsion-type composition for external use
GR3035613T3 (en) Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
JP2006524234A (ja) アスコルビン酸の安定化誘導体
PL339255A1 (en) Hair treating composition
Stewart et al. The fatty acids of human sebaceous gland phosphatidylcholine
JPH0680547A (ja) 皮膚外用剤
RU95104211A (ru) Крем для ухода за кожей

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载